VTCN1 and neoplasm: In ovarian cancer, TAMs expressing B7-H4 (a member of the B7 superfamily; V-set domain containing T cell activation inhibitor 1, [83] gene) suppress the activation of antigen-specific T-cells; and CCL22 secreted by TAMs recruits CCR4-expressing Tregs and promotes tumour growth [84].